Abstract
HIV-1 is equipped with the envelope gp160 glycoprotein for interaction with Langerhans cells (LCs) and dendritic cells (DCs), the members of the innate immune system, which confront the virus at the portal of virus entry in the human body. These cells are equipped with receptors by which they bind and endocytose the virus. The gp120 glycoprotein is used for binding to CD4 receptor and CCR5 co-receptor of T helper 2 (Th2) cells and the virions shed gp120 is able to induce FcεRI+ hematopoietic cells to produce IL-4, which inactivate the host adaptive immune response. The properties of gp120s various functional domains are analyzed together with the regulatory viral proteins, which are involved in the damage to T and B cells during HIV-1 replication. The interaction of HIV-1 virions through their gp120 with LCs and DCs at the portal of virus entry will be discussed. A hypothesis will be presented that the understanding of the role of the different functional domains of gp120 in the life cycle of the virus and during AIDS will help in the design of approaches to prevent and abrogate HIV-1 infection and AIDS.
Similar content being viewed by others
References
Sabin A.B., Proc Natl Acad Sci USA 89, 8852–8859, 1992.
(No authors listed), Drugs R D 4, 249–253, 2003.
Leung D.Y.M., Mol Genet Metabol 63, 157–167, 1998.
Albarse R.C., J Allergy Clin Immunol 106, 228–238, 2000.
Patella V., Giuliano A., Bouvet J.P., and Marone G., J Immunol 161, 5647–5655, 1998.
Becker Y., Virus Genes 27, 269–282, 2003.
Becker Y., Virus Genes 28, 1–14, 2004.
Clerici M. and Shearer G.M., Immunol Today 14, 107–111, 1993.
Karray S. and Zouali M., Proc Natl Acad Sci USA 94, 1356–1360, 1997.
Karray S., Juompan L., Maroun R.C., Isenberg D., Silverman G.J., and Zouali M., J Immunol 161, 6681–6688, 1998.
Becker Y., Virus Genes 28, 319–331, 2004.
Zhu P., Chertova F., Bess J. Jr., Lifson J.D., Arthur L.O., Lu J., Taylor X.A., and Roux K.H., Proc Natl Acad Sci USA 100, 15812–15817, 2003.
Adams D. and Scheid A., AIDS Res Human Retroviruses 17, 1345–1356, 2001.
Becker Y., Virus Genes 8, 249–270, 1994.
Srivasata S.K., Stamatatos L., Kan E., Vajdy M. Lian Y., Hilt S., Martin L., et al., J Virol 77, 11244–11259, 2003.
Willey R.L., Bonifacino J.S., Potts B.J., Martin M.A., and Klausner R.D., Proc Natl Acad Sci USA 85, 9580–9584, 1988.
McCune J.M., Rabin L.B., Feinberg M.B., Lieberman M., Kosek J.C., Reyes G.R., and Weissman I.L., Cell 53, 55–67, 1988.
Gelderblom H.R., Hausman E.H.S., Özel M., Pauli G., and Koch M.A., Virology 156, 171–176, 1987.
Wyatt R. and Sodroski J., Science 280, 1884–1888, 1998.
Poignard P., Saphire E.O., Whi Parren P., and Burton D.R., Annu Rev Immunol 19, 253–274, 2001.
Li Y., Luo L., Rasool N., and Kang C.Y., J Virol 67, 584–588, 1993.
Rizzuto C.D., Wyatt R., Hernandez-Ramos N., Sun Y., Kwong P.D., Hendrikson W.A., and Sodroski J., Science 280, 1949–1953, 1998.
Bariband F., Pöxhlman S., and Dons R.W., Virology 286, 1–6, 2001.
Twirville S.G., Arthos J., MacDonald K., Lynch G., Naif H., Clark G., Hart D., and Cunningham A.L., Blood 98, 2482–2488, 2001.
Berberian L., Goodglick L., Kipps T.J., and Braun J., Science 261, 1588–1591, 1993.
Goodglick L., Zevil N., Nesat M.S., and Braun J., J Immunol 155, 5151–5159, 1995.
Juompan L., Lambin P., and Zouali M., FASEB J 12, 1473–1480, 1998.
Florio G. Petraroli A., Patella V., Tiggiani M., and Marone G., AIDS 14, 931–938, 2000.
Takahashi M., Osono E., Nakagaway Y., Wang J., Berzofsky J.A., Margulies D.H., and Takahashi H., J Immunol 169, 6588–6593, 2002.
Javaherian K., Langlois A.J., McDanal C., Ross K.L., Eckler L., Jellis C.L., Profy A.T., Rusche J.R., Bolognesi D.P., Putney S.D., and Matthews T.J., Proc Natl Acad Sci USA 86, 6768–6772, 1989.
Boudet F., Girard M., Theze J., and Zouali M. Int Immunol 4, 283–294, 1992.
Wyatt R., Kwong P.D., Desjardin E., Sweet R.W., Robinson J., Hendrickson W.A., and Sodroski J.G., Nature 393, 705–710, 1998.
Moore J.P., Sattentau Q.J., Yoshiyama H., Thall M., Charles M., Sullivan N., Doon S.-W., Fung M.S., Traincard F., Pinkus M., Robey G., Robinson J.E., Ho D.D., Sodroski J., J Virol 67, 6136–6151, 1993.
Cao J., Sullivan N., Desjardin E., Parolin C., Robinsion J., Wyatt R., and Sodroski Y., J Virol 71, 9808–9812, 1997.
Stamatatos L., Wiskerchen M., and Cheng-Mayer C., AIDS Res Human Retroviruses 14, 1129–1139, 1998.
Kmieciak D., Wasik T.J., Teppler H., Pientka J., Hsu S.H., Takahshi H., Okumura K., Kaneko Y., and Kozbor D., J Immunol 160, 5676–5683, 1998.
Kiszka I., Kmieciak D., Gzyl J., Naito T., Bolesta E., Sieron A., Singh S.P., Srinivasan A., Trinchierti G., Kaneko Y., and Kozbor D., J Virol 76, 4222–4232, 2002.
Garrity R.R., Rimmelzwaan G., Minassian A., Tsai W.P., Lin G., deJong J.J., Goodsmit J., and Nara P.L., J Immunol 159, 279–289, 1997.
Binley J.M., Sanders R.W., Clas B., Schuelke N., Master A., Guo Y., Kajamo F., Anselma D.J., Maddon P.J., Olson W.C., and Moore J.P., J Virol 74, 627–643, 2000.
Edwards T.G., Wyss S., Reeves J.D., Zolla-Pazner S., Hoxie J.A., Doms R.W., and Bariband F., J Virol 76, 2683–2691, 2002.
Prljic J., Veljković N, Doliana R., Colombati A., Johnson E., Metla Ś, and Veljković V., Vaccine 17, 1462–1467, 1999.
de Paulis A., de Palma R., DiGioia L., Carfora M., Prevete N., Tosi G., Accola R.S., and Marone G., J Immunol 165, 7171–7179, 2000.
Pu H., Tian J., Flora G., Lee Y.W., Nath A., Henning B., and Toborek M., Mol Cell Neurosci 24, 224–237, 2003.
Caldwell R.L., Egan B.S., and Shepherd V.L., J Immunol 165, 7035–7041, 2000.
Agwale S.M., Shata M.T. Reitz M.S., Kalyanaraman V.S., Gallo R.C., Popovic M., and Hone D.M., Proc Nat Acad Sci USA 99, 10037–10041, 2002.
Voss G. Manson K. Motefiori D., Watkins D.I., Heeny J., Wyand M., Cohen J., and Bruck C., J Virol 77, 1049–1058, 2003.
Tichonov I., Ruckwardt T.J., Hatfield G.S., and Pauza C.D., J Virol 77, 3157–3166, 2003.
Noonan D.M., Gringeri A., Meazza R., Rosso O., Mazza S., Muca-Perja M., Le Buanec H., Accolla R.S., Albini A., and Ferrini S., J Acquir Immune Defic Syndr 33, 47–55, 2003.
Kim D.T., Mitchell D.J., Brockstedt D.G., Fong L., Nolan G.P., Fathman C.G., Engelman E.G., and Rothbard J.B., J Immunol 159, 1666–1668, 1997.
Kim T.-G. and Langridge W.H.R., Plant Cell Rep 22, 382– 387, 2004.
Tungaturthi P.K., Sawaya B.E., Sing S.P., Tomkowicz B., Ayyavoo V., Khalili K., Collman R.G., Amin S., and Srinivasan A., Biomed Pharmacother 57, 20–24, 2003.
Ayyavoo V., Muthumani K., Kudchodar S., Zhang D., Ramanatan P., Dayes N.S., Kim J.J., Sin J.I., Montaner L.J., and Weiner D.B., Int Immunol 14, 13–22, 2002.
Casortelli N., Di Matteo G., Potesta M., Rossi P., and Doria M., J Virol 77, 11536–11545, 2003.
Salvi R., Garbuglia A.R., Di Carlo A., Pulciani S., Moutella F., and Benedetto A., J Virol 72, 3646–3651, 1998.
Kavanagh D.G. and Bhardwaj N., Nat Immunobiol 3, 891–893, 2002.
Soilleux E.J. and Coleman N., J Clin Pathol 57, 77–78, 2004.
Cambi A., de Lang F., van Moarseveen N.H., Nijhuis M., Joosten B., van Dijk E.M.H.P., de Baaker B.I., et al., J Cell Biol 164, 145–155, 2004.
Kelleher P., Maroof A., and Night S.G., Eur J Immunol 29, 2309–2318, 1999.
Figdor C.G., van Kooyk Y., and Adema G.J., Nat Rev Immunol 2, 77–84, 2002.
Geijtenbeek T.B.H., and van Kooyk Y., APMIS 111, 698–714, 2003.
Liu H., Yu W., Liou L.-Y., and Rice A.P., Gene 313, 149–159, 2003.
Valladeau J., Ravel O., Dezzutter-Dambuyant C., Moore K., Kleijmeer M., Liu Y., et al., Immunity 12, 71–81, 2000.
Birbeck M.S., Breathnach A.S., and Everall J.D., J Invest Dermatol 37, 51–64, 1961.
McDermott R., Ziylan U., Spehner D., Bausinger H., Lipsker D., et al., Mol Biol Cell 13, 317–335, 2002.
Salleisto F., Cella M., Danieli C., and Lanzavecchia A., J Exp Med 182, 389–400, 1995.
Pieters J. Adv Immunol 75, 159–208, 2000.
Engering A., Geijtenbeck T.B., van Vliet S.J., Wijers M., Van Liempt E., et al., J Immunol 168, 2118–2126, 2002.
Larsson M. Fonteneau J.F., and Bhardwaj N., Trends Immunol 22, 141–148, 2001
Moris A., Nobile C., Buseyne F., Porrot F., Abastodo J.-P., and Schwartz O., Blood, October 23, 2003 (prepublished on-line).
Shacklett B.L., Means R.E., Larsson M., Wilkens D.T., Beadle T.J., et al., AIDS Res Human Retroviruses 18, 805–815, 2002.
Rowland-Jones S.L., Dong T., Dorrell L., Ogg G., Hansasuta P., Krausa P., et al., Immunol Lett. 66, 9–14, 1999.
Hong P.W.-F., Flummerfelt K.B., de Parseval A., Gurvey K., Elder I.H., and Lee B., J Virol 76, 12855–12865, 2002.
Feinberg H., Mitchell D.A., Drickamer K., and Weiss W.I., Science 294, 2163–2166, 2001.
Koch M., Pancera M., Kwong P.P., Kolchinsky P., Grudner C., Wang L., Hendrickson W.A., Sodroski J., and Wyatt R., Virology 313, 387–400, 2003.
Calarese D.A., Scanlan C.N., Zwick M.B., Deechongkit S., Mimura Y., et al., Science 300, 2065–2071, 2003.
Deslee G., Charbonnier A.-S., Hammad H., Angialosi G., Tille-Lebond I., et al., J Allergy Clin Immunol 110, 763–770, 2002.
Wollenberg A., Mommoas M., Oppel T., Schottdorf E.-M., Günther S., and Morderer M., J Invest Dermatol 118, 327–334, 2002.
Nguyen D.G. and Hildreth E.K., Eur J Immunol 33, 483–493, 2003.
Prigozy T.I., Sieling P.A., Clemens D., Stewart P.L., Behar S.M., et al., Immunity 6, 187–197, 1997.
Gummurulu S., Rogel M., Stamatatos L., and Enerman M., J Virol 77, 12865–12874, 2003.
Akira S., Takeda K., and Kaisho T., Nat Immunol 2, 675–680, 2001.
Equils O., Schito M.L., Karahashi H., Modak Z., Yarali A., Michelson K.S., Sher A., and Arditi M., J Immunol 170, 5159–5164, 2003.
Bafica A., Scanga C.A., Schito M.L., Hieny S., and Sher A., J Immunol 171, 1123–1127, 2003.
Lore´ K., Betts M.R., Brenchly J.M., Kuruppu J., Khojasteh S., Perfetto S., Roederer M., Seder R.A., and Koup R.A., J Immunol 171, 4320–4328, 2003.
Zheng L., Huang X.-L., Fan Z., Borowski L., Wilson C.C., and Rinaldo C.R., AIDS Res Human Retroviruses 15, 1011–1020, 1999.
An H., Yu Y., Zhang M., Xu H., Qi R., Yan X., et al., Immunology 106, 38–45, 2002.
Xie J., Qian J., Wang s., Freeman III M.E., Epstein J., and Yi Q., J Immunol 171, 4792–4800, 2003.
Kaisho T., Takeuchi D., Kawai T., Hoshino K., and Akira S., J Immunol 166, 5688–5694, 2001.
Jeamin P., Renno T., Goetsch L., Miconnet I., Aubry J.-P., et al., Nat Immunol 1, 502–509, 2000.
Montefiori D.C., Stewart K., Ahearn J.M., Zhou J., and Zhou J, J Virol 67, 2699–2706, 1993.
Cao X., Sugita M., Vander der Wel N., Lai J., Rogers R.A., Peters P.J., and Brenner M.B., J Immunol 169, 4770–4777, 2002.
Pena-Cruz V., Ito Dascher C.C., Brenner M.B., and Sugita M., J Invest Dermatol 121, 517–521, 2003.
Branch Moody B., Briken V., Cheng T.-Y., Roura-Mir C., Guy M.R., et al., Nat Immunol 3, 435–442, 2002.
Nishimura T., Kitamura H., Iwakabe K., Yahata T., Ohna A., et al., Int Immunol 12, 987–994, 2002.
Tsai C.-C., Emau P., Jiang Y., Tian B., Morton W.R., Gustafson K.R., and Boyd M.R., AIDS Res Human Retroviruses 19, 535–541, 2003.
Tsai C.-C., Emau P., Jiang Y., Agy M.B., Shattock R.J., Schmidt R.J., Morton W.R., Gustafson K.R., and Boyd M.R., AIDS Res Human Retroviruses 20, 11–18, 2004.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Becker, Y. HIV-1 gp120 Binding to Dendritic Cell Receptors Mobilize the Virus to the Lymph Nodes, but the Induced IL-4 Synthesis by FcεRI+ Hematopoietic Cells Damages the Adaptive Immunity – a Review, Hypothesis, and Implications. Virus Genes 29, 147–165 (2004). https://doi.org/10.1023/B:VIRU.0000032797.43537.d3
Issue Date:
DOI: https://doi.org/10.1023/B:VIRU.0000032797.43537.d3